A study of Landscape of human antibody recognition of the SARS-CoV-2 Receptor Binding Domain. Wheatley and Pymm et al
Published: 15 September 2021| Version 1 | DOI: 10.17632/zvw3yfpk4g.1
Table S1. Antibody binding, neutralisation and sequences from convalescent patients, Related to Figure 1. Table S2. Antibody binding, neutralisation and sequences from semi-synthetic human Fab library, Related to Figure 2. Table S5. Summary of interactions between SARS-CoV-2 RBD and human antibodies, Related to Figure 3 and 7.
Severe Acute Respiratory Syndrome Coronavirus 2